ArticleJCEM case reports2025
Primary Renal Neuroendocrine Tumor Presenting as Ectopic ACTH Syndrome.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms.Current treatment options in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ectopic adrenocorticotropin syndrome (EAS) is rarely caused by genitourinary neuroendocrine tumors (NETs). We describe an unusual case of renal NET presenting with severe EAS. A 32-year-old woman had presented to endocrine clinic with a 2-month history of proximal muscle weakness, skin hyperpigmentation, amenorrhea, and weight gain. She was hypertensive (160/90 mm Hg) with facial puffiness, hirsutism, and obesity. Investigations suggested high 8 Am cortisol, 24-hour urine free cortisol, and high adrenocorticotropin level. She required inpatient admission because of worsening symptoms, and work-up revealed severe hypokalemia and hyperglycemia requiring intravenous (IV) potassium chloride and IV insulin. Radiology revealed normal sella on magnetic resonance imaging and a mass in the upper pole of the right kidney along with bilateral adrenal enlargement on computed tomography. The patient underwent surgical resection of the right renal mass. The initial histopathology revealed renal oncocytoma, with no evidence of renal cell carcinoma, which was revisited with additional immunochemistry. Final histopathology confirmed primary renal well-differentiated NET. The abruptness and severity of symptoms favored aggressive neoplasm but histopathology confirmed an extremely rare example of primary renal NET and ruled out malignancy. This case highlights the presentation of severe EAS in a patient with extremely rare renal NET.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.